MADISON, Wis., July 24, 2013 (GLOBE NEWSWIRE) — Cellular Dynamics
International, Inc., a developer and manufacturer of fully functioning
human cells in industrial quantities to precise specifications, today
announced the pricing of its initial public offering of 3,846,000
shares of common stock at a price to the public of $12.00 per share.
The shares are expected to begin trading on The Nasdaq Global Market on
July 25, 2013, under the symbol “ICEL.” In addition, the underwriters
have a 30-day option to purchase up to an additional 576,900 shares of
common stock from the Company.
The Company intends to use the net proceeds that it receives in the
offering for research and product development activities; sales and
marketing activities, including expansion of its sales force to support
the ongoing commercialization of its products; property, plant and
equipment, including the build-out of its laboratory in California, and
intellectual property; and for working capital and other general
corporate purposes.
J.P. Morgan Securities LLC is acting as sole book-running manager for
the offering, and Cowen and Company, LLC and Leerink Swann LLC are
acting as co-managers.
A Registration Statement relating to these securities was declared
effective by the U.S. Securities and Exchange Commission (“SEC”) on
July 24, 2013. This press release shall not constitute an offer to sell
or a solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
The offering will be made only by means of a prospectus. Copies of the
prospectus relating to the offering, when available, may be obtained
from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood, New York 11717; telephone (866)
803-9204.
Forward-looking Statements
This press release includes “forward-looking statements,” including
with respect to the Company’s initial public offering and the Company’s
intended use of proceeds. Forward-looking statements are subject to
known and unknown risks and uncertainties, many of which may be beyond
the Company’s control. The forward-looking information presented in
this press release is not a guarantee of future events, and actual
events may differ materially from those made in or suggested by the
forward-looking information contained in this press release. In
addition, forward-looking statements generally can be identified by the
use of forward-looking terminology such as “may,” “plan,” “seek,”
“expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue”
or the negative thereof or variations thereon or similar terminology.
Any forward-looking information presented herein is made only as of the
date of this press release, and the Company does not undertake any
obligation to update or revise any forward-looking information to
reflect changes in assumptions, the occurrence of unanticipated events,
or otherwise.
CONTACT:
Joleen Rau
Senior Director, Marketing & Communications
Cellular Dynamics International, Inc.
608 310-5142
jrau@cellulardynamics.com
Investor Relations
Gitanjali Jain Ogawa
The Trout Group, LLC
646 378-2949
gogawa@troutgroup.com
